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I T has previously been reported that pretreatment of human islets with anti-MHC class I antibodies leads to 
their prolonged survival when subsequently transplanted 
into naive mice, suggesting that, as in allotransplantation, 
these molecules also playa role in the recognition and the 
initiation of effector responses to xenoantigens,l However, 
this protracted survival of cellular, unlike primary vascular-
ized organ transplants, can also be ascribed partially to their 
inherent resistance to antibody-mediated injury; a feature 
largely attributed to the neovasculature. which is essentially 
of recipient origin. Of the vascularized organs, liver but not 
heart xenografts are an exception: they are relatively resis-
tant to humoral rejection. thereby allowing for the devel-
opment of cell-mediated responses." This peculiar observa-
tion provides a unique opportunity to study the role of 
donor MHC class I and class II cell surface molecules in the 
acceptance or rejection of primary vascularized xenografts. 
To this end. we used MHC class I and class II "knock out" 
mice as donors of organs (liver and heart), which were 
transplanted into naive rat recipients. Furthermore, the 
influence of MHC disparity on xenograft survival in the 
reciprocal (rat to mouse) combination was also investi-
gated. 
MATERIALS AND METHODS 
Rat to Mouse Experiments. Hearts ohtained from 2- to 3-week-
old ACI (RTla) or LEW (RTl') rats were heterotopically trans-
planted into adult BIO or C3H mice. 
Mouse 10 Rat Experiments. Hearts (heterotopic) or livers (ortho-
topic) were transplanted from normal C3H (H_2k ). BIO (H_2h). B6 
(H_2h ). or MHC class 1 (B6: b2m) or class II (86: CD2) deficient 
mice into naive 3- to 4-week-old LEW recipients. 
RESULTS AND DISCUSSION 
Rat to Mouse. C3H mice rejected LEW and ACI hearts 
in 5.6 ± 0.5 and 7.1 ± 0.8 days, respectively (P < .0(01). 
whereas 810 mice rejected these grafts in 8.5 ± 0.7 and 
7.7 ± D.7 days. respectively (P < .(03). Histopathological 
analysis of rejected cardiac xenografts revealed mononu-
clear cell intiltration with widespread thrombosis. 
Mouse to Rat. Hearts obtained from 810. C3H. or 86 
mice. when transplanted into LEW rats. were rejected in 
732 
<3 days. Similar survival was also noted when hearts from 
MHC class I or class II knock out mice were transplanted 
into naive LEW recipients. The predominant effector mech-
anism appeared to be humoral. because histopathological 
analysis revealed widespread thrombosis and interstitial 
hemorrhage with mild cellular infiltration. Unlike hearts. 
mouse livers obtained from naive animals enjoyed pro-
longed survival (6 to 10 days) when transplanted into LEW 
rats. However, similar to our observations in hearts, the lack 
of expression of class I or class II antigens in the trans-
planted liver had no appreciable effect on prolonging its 
survival following transplantation. Interestingly. no discern-
ible difference was noted in the titers of rat antimouse 
cytotoxic antibodies in the serum of LEW recipients of 
hearts or livers from b2m. CD2, or normal 86 mice. 
Taken together, these observations suggest that the ex-
pression of donor MHC class I and class II cell-surface 
antigens may have an insignificant role in determining the 
tempo of rejection of xenografts transplanted from mouse 
to rat. It is therefore tempting to speculate that in this 
model. species-specific epitopes may playa more dominant 
role than MHC antigens in eliciting humoral or cellular 
responses. 
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